Industry: Medical Devices & Consumables
Published Date: 2024-01-12
Pages: 122 Pages
Report ld: 2650321
Request Sample
Customized Report
Implantable neurostimulation system are implantable, programmable medical devices that deliver electrical stimulation to specific parts of the patient's brain, spinal cord or peripheral nervous system to help treat various conditions, including chronic pain, movement disorders, epilepsy and Parkinson's disease.
The global market for Implantable Neurostimulation System was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Implantable Neurostimulation System was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Implantable Neurostimulation System was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Implantable Neurostimulation System was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Implantable Neurostimulation System include Medtronic, Abbott, Nevro, Boston Scientific, Mainstay Medical, Cochlear, Nalu Medical, LivaNova and ReShape Lifesciences, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Implantable Neurostimulation System, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Implantable Neurostimulation System by region & country, by Type, and by Application.
The Implantable Neurostimulation System market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Implantable Neurostimulation System.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Implantable Neurostimulation System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Implantable Neurostimulation System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Implantable Neurostimulation System in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Implantable Neurostimulation System Product Introduction
1.2 Global Implantable Neurostimulation System Market Size Forecast
1.2.1 Global Implantable Neurostimulation System Sales Value (2019-2030)
1.2.2 Global Implantable Neurostimulation System Sales Volume (2019-2030)
1.2.3 Global Implantable Neurostimulation System Sales Price (2019-2030)
1.3 Implantable Neurostimulation System Market Trends & Drivers
1.3.1 Implantable Neurostimulation System Industry Trends
1.3.2 Implantable Neurostimulation System Market Drivers & Opportunity
1.3.3 Implantable Neurostimulation System Market Challenges
1.3.4 Implantable Neurostimulation System Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Implantable Neurostimulation System Players Revenue Ranking (2023)
2.2 Global Implantable Neurostimulation System Revenue by Company (2019-2024)
2.3 Global Implantable Neurostimulation System Players Sales Volume Ranking (2023)
2.4 Global Implantable Neurostimulation System Sales Volume by Company Players (2019-2024)
2.5 Global Implantable Neurostimulation System Average Price by Company (2019-2024)
2.6 Key Manufacturers Implantable Neurostimulation System Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Implantable Neurostimulation System Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Implantable Neurostimulation System
2.9 Implantable Neurostimulation System Market Competitive Analysis
2.9.1 Implantable Neurostimulation System Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Implantable Neurostimulation System Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Implantable Neurostimulation System as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Spinal Cord Stimulation (SCS) Systems
3.1.2 Deep Brain Stimulation (DBS) System
3.1.3 Cochlear Implants
3.1.4 Others
3.2 Global Implantable Neurostimulation System Sales Value by Type
3.2.1 Global Implantable Neurostimulation System Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Implantable Neurostimulation System Sales Value, by Type (2019-2030)
3.2.3 Global Implantable Neurostimulation System Sales Value, by Type (%) (2019-2030)
3.3 Global Implantable Neurostimulation System Sales Volume by Type
3.3.1 Global Implantable Neurostimulation System Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Implantable Neurostimulation System Sales Volume, by Type (2019-2030)
3.3.3 Global Implantable Neurostimulation System Sales Volume, by Type (%) (2019-2030)
3.4 Global Implantable Neurostimulation System Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals & Clinics
4.1.2 Cognitive Care Centers
4.1.3 Research Institutes
4.1.4 Others
4.2 Global Implantable Neurostimulation System Sales Value by Application
4.2.1 Global Implantable Neurostimulation System Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Implantable Neurostimulation System Sales Value, by Application (2019-2030)
4.2.3 Global Implantable Neurostimulation System Sales Value, by Application (%) (2019-2030)
4.3 Global Implantable Neurostimulation System Sales Volume by Application
4.3.1 Global Implantable Neurostimulation System Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Implantable Neurostimulation System Sales Volume, by Application (2019-2030)
4.3.3 Global Implantable Neurostimulation System Sales Volume, by Application (%) (2019-2030)
4.4 Global Implantable Neurostimulation System Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Implantable Neurostimulation System Sales Value by Region
5.1.1 Global Implantable Neurostimulation System Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Implantable Neurostimulation System Sales Value by Region (2019-2024)
5.1.3 Global Implantable Neurostimulation System Sales Value by Region (2025-2030)
5.1.4 Global Implantable Neurostimulation System Sales Value by Region (%), (2019-2030)
5.2 Global Implantable Neurostimulation System Sales Volume by Region
5.2.1 Global Implantable Neurostimulation System Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Implantable Neurostimulation System Sales Volume by Region (2019-2024)
5.2.3 Global Implantable Neurostimulation System Sales Volume by Region (2025-2030)
5.2.4 Global Implantable Neurostimulation System Sales Volume by Region (%), (2019-2030)
5.3 Global Implantable Neurostimulation System Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Implantable Neurostimulation System Sales Value, 2019-2030
5.4.2 North America Implantable Neurostimulation System Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Implantable Neurostimulation System Sales Value, 2019-2030
5.5.2 Europe Implantable Neurostimulation System Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Implantable Neurostimulation System Sales Value, 2019-2030
5.6.2 Asia Pacific Implantable Neurostimulation System Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Implantable Neurostimulation System Sales Value, 2019-2030
5.7.2 South America Implantable Neurostimulation System Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Implantable Neurostimulation System Sales Value, 2019-2030
5.8.2 Middle East & Africa Implantable Neurostimulation System Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Implantable Neurostimulation System Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Implantable Neurostimulation System Sales Value
6.2.1 Key Countries/Regions Implantable Neurostimulation System Sales Value, 2019-2030
6.2.2 Key Countries/Regions Implantable Neurostimulation System Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Implantable Neurostimulation System Sales Value, 2019-2030
6.3.2 United States Implantable Neurostimulation System Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Implantable Neurostimulation System Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Implantable Neurostimulation System Sales Value, 2019-2030
6.4.2 Europe Implantable Neurostimulation System Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Implantable Neurostimulation System Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Implantable Neurostimulation System Sales Value, 2019-2030
6.5.2 China Implantable Neurostimulation System Sales Value by Type (%), 2023 VS 2030
6.5.3 China Implantable Neurostimulation System Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Implantable Neurostimulation System Sales Value, 2019-2030
6.6.2 Japan Implantable Neurostimulation System Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Implantable Neurostimulation System Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Implantable Neurostimulation System Sales Value, 2019-2030
6.7.2 South Korea Implantable Neurostimulation System Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Implantable Neurostimulation System Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Implantable Neurostimulation System Sales Value, 2019-2030
6.8.2 Southeast Asia Implantable Neurostimulation System Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Implantable Neurostimulation System Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Implantable Neurostimulation System Sales Value, 2019-2030
6.9.2 India Implantable Neurostimulation System Sales Value by Type (%), 2023 VS 2030
6.9.3 India Implantable Neurostimulation System Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Medtronic
7.1.1 Medtronic Company Information
7.1.2 Medtronic Introduction and Business Overview
7.1.3 Medtronic Implantable Neurostimulation System Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Medtronic Implantable Neurostimulation System Product Offerings
7.1.5 Medtronic Recent Development
7.2 Abbott
7.2.1 Abbott Company Information
7.2.2 Abbott Introduction and Business Overview
7.2.3 Abbott Implantable Neurostimulation System Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Abbott Implantable Neurostimulation System Product Offerings
7.2.5 Abbott Recent Development
7.3 Nevro
7.3.1 Nevro Company Information
7.3.2 Nevro Introduction and Business Overview
7.3.3 Nevro Implantable Neurostimulation System Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Nevro Implantable Neurostimulation System Product Offerings
7.3.5 Nevro Recent Development
7.4 Boston Scientific
7.4.1 Boston Scientific Company Information
7.4.2 Boston Scientific Introduction and Business Overview
7.4.3 Boston Scientific Implantable Neurostimulation System Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Boston Scientific Implantable Neurostimulation System Product Offerings
7.4.5 Boston Scientific Recent Development
7.5 Mainstay Medical
7.5.1 Mainstay Medical Company Information
7.5.2 Mainstay Medical Introduction and Business Overview
7.5.3 Mainstay Medical Implantable Neurostimulation System Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Mainstay Medical Implantable Neurostimulation System Product Offerings
7.5.5 Mainstay Medical Recent Development
7.6 Cochlear
7.6.1 Cochlear Company Information
7.6.2 Cochlear Introduction and Business Overview
7.6.3 Cochlear Implantable Neurostimulation System Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Cochlear Implantable Neurostimulation System Product Offerings
7.6.5 Cochlear Recent Development
7.7 Nalu Medical
7.7.1 Nalu Medical Company Information
7.7.2 Nalu Medical Introduction and Business Overview
7.7.3 Nalu Medical Implantable Neurostimulation System Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Nalu Medical Implantable Neurostimulation System Product Offerings
7.7.5 Nalu Medical Recent Development
7.8 LivaNova
7.8.1 LivaNova Company Information
7.8.2 LivaNova Introduction and Business Overview
7.8.3 LivaNova Implantable Neurostimulation System Sales, Revenue and Gross Margin (2019-2024)
7.8.4 LivaNova Implantable Neurostimulation System Product Offerings
7.8.5 LivaNova Recent Development
7.9 ReShape Lifesciences
7.9.1 ReShape Lifesciences Company Information
7.9.2 ReShape Lifesciences Introduction and Business Overview
7.9.3 ReShape Lifesciences Implantable Neurostimulation System Sales, Revenue and Gross Margin (2019-2024)
7.9.4 ReShape Lifesciences Implantable Neurostimulation System Product Offerings
7.9.5 ReShape Lifesciences Recent Development
7.10 Inspire Medical
7.10.1 Inspire Medical Company Information
7.10.2 Inspire Medical Introduction and Business Overview
7.10.3 Inspire Medical Implantable Neurostimulation System Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Inspire Medical Implantable Neurostimulation System Product Offerings
7.10.5 Inspire Medical Recent Development
8 Industry Chain Analysis
8.1 Implantable Neurostimulation System Industrial Chain
8.2 Implantable Neurostimulation System Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Implantable Neurostimulation System Sales Model
8.5.2 Sales Channel
8.5.3 Implantable Neurostimulation System Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Implantable Neurostimulation System was estimated to be worth US$ 6536 million in 2025 and is projected to reach US$ 12780 million, growing at a CAGR of 10.2% from 2026 to 2032.
Published Date: 2026-02-11
Pages: 91
USD 3950.00
(Single User License)
The global Implantable Neurostimulation System market was valued at US$ 6536 million in 2025 and is anticipated to reach US$ 12780 million by 2032, at a CAGR of 10.2% from 2026 to 2032.
Published Date: 2026-02-11
Pages: 117
USD 2900.00
(Single User License)
The global Implantable Neurostimulation System market is projected to grow from US$ 5986 million in 2024 to US$ 11700 million by 2031, at a CAGR of 10.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-03
Pages: 131
USD 4900.00
(Single User License)
The global Implantable Neurostimulation System market size was US$ 5986 million in 2024 and is forecast to a readjusted size of US$ 11700 million by 2031 with a CAGR of 10.2% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 80
USD 4250.00
(Single User License)
The global market for Implantable Neurostimulation System was estimated to be worth US$ 5986 million in 2024 and is forecast to a readjusted size of US$ 11700 million by 2031 with a CAGR of 10.2% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 99
USD 3950.00
(Single User License)
The global market for Implantable Neurostimulation System was valued at US$ 5986 million in the year 2024 and is projected to reach a revised size of US$ 11700 million by 2031, growing at a CAGR of 10.2% during the forecast period.
Published Date: 2025-02-14
Pages: 78
USD 2900.00
(Single User License)
The global market for Implantable Neurostimulation System was estimated to be worth US$ 5438 million in 2023 and is forecast to a readjusted size of US$ 10720 million by 2030 with a CAGR of 10.2% during the forecast period 2024-2030.
Published Date: 2024-12-24
Pages: 94
USD 3950.00
(Single User License)
The global Implantable Neurostimulation System revenue was US$ 5438 million in 2023 and is forecast to a readjusted size of US$ 10720 million by 2030 with a CAGR of 10.2% during the review period (2024-2030).
Published Date: 2024-12-24
Pages: 101
USD 4350.00
(Single User License)
The global market for Implantable Neurostimulation System was valued at US$ 5438 million in the year 2023 and is projected to reach a revised size of US$ 10720 million by 2030, growing at a CAGR of 10.2% during the forecast period.
Published Date: 2024-12-24
Pages: 83
USD 2900.00
(Single User License)
Valued at US$ 5986 million in 2024, the global Implantable Neurostimulation System market is forecast to reach US$ 10720 million by 2030, at a CAGR of 10.2% during the forecast period.
Published Date: 2024-12-24
Pages: 130
USD 4900.00
(Single User License)
The global market for Implantable Neurostimulation System was estimated to be worth US$ 6536 million in 2025 and is projected to reach US$ 12780 million, growing at a CAGR of 10.2% from 2026 to 2032.
Published: 2026-02-11
Pages: 91
The global Implantable Neurostimulation System market was valued at US$ 6536 million in 2025 and is anticipated to reach US$ 12780 million by 2032, at a CAGR of 10.2% from 2026 to 2032.
Published: 2026-02-11
Pages: 117
The global Implantable Neurostimulation System market is projected to grow from US$ 5986 million in 2024 to US$ 11700 million by 2031, at a CAGR of 10.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 131
The global Implantable Neurostimulation System market size was US$ 5986 million in 2024 and is forecast to a readjusted size of US$ 11700 million by 2031 with a CAGR of 10.2% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 80
The global market for Implantable Neurostimulation System was estimated to be worth US$ 5986 million in 2024 and is forecast to a readjusted size of US$ 11700 million by 2031 with a CAGR of 10.2% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 99
The global market for Implantable Neurostimulation System was valued at US$ 5986 million in the year 2024 and is projected to reach a revised size of US$ 11700 million by 2031, growing at a CAGR of 10.2% during the forecast period.
Published: 2025-02-14
Pages: 78
The global market for Implantable Neurostimulation System was estimated to be worth US$ 5438 million in 2023 and is forecast to a readjusted size of US$ 10720 million by 2030 with a CAGR of 10.2% during the forecast period 2024-2030.
Published: 2024-12-24
Pages: 94
The global Implantable Neurostimulation System revenue was US$ 5438 million in 2023 and is forecast to a readjusted size of US$ 10720 million by 2030 with a CAGR of 10.2% during the review period (2024-2030).
Published: 2024-12-24
Pages: 101
The global market for Implantable Neurostimulation System was valued at US$ 5438 million in the year 2023 and is projected to reach a revised size of US$ 10720 million by 2030, growing at a CAGR of 10.2% during the forecast period.
Published: 2024-12-24
Pages: 83
Valued at US$ 5986 million in 2024, the global Implantable Neurostimulation System market is forecast to reach US$ 10720 million by 2030, at a CAGR of 10.2% during the forecast period.
Published: 2024-12-24
Pages: 130
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now